Mind the gap in kidney care: translating what we know into what we do

Author:

Luyckx Valerie A.1ORCID,Tuttle Katherine R.2ORCID,Abdellatif Dina3ORCID,Correa-Rotter Ricardo4ORCID,Fung Winston W.S.5ORCID,Haris Agnès6ORCID,Hsiao Li-Li7ORCID,Khalife Makram8,Kumaraswami Latha A.9ORCID,Loud Fiona8ORCID,Raghavan Vasundhara8,Roumeliotis Stefanos10ORCID,Sierra Marianella8,Ulasi Ifeoma11ORCID,Wang Bill8ORCID,Lui Siu-Fai12ORCID,Liakopoulos Vassilios10ORCID,Balducci Alessandro13ORCID

Affiliation:

1. University of Zurich, Epidemiology, Switzerland; Harvard Medical School, USA; University of Cape Town, South Africa

2. Providence Inland Northwest Health, USA; University of Washington, USA

3. Cairo University Hospital, Egypt

4. National Medical Science and Nutrition Institute Salvador Zubiran, Mexico

5. University of Hong Kong, China

6. Péterfy Hospital, Hungary

7. Harvard Medical School, USA

8. ISN Patient Liaison Advisory Group, Belgium

9. Tamilnad Kidney Research (TANKER) Foundation, India

10. Aristotle University of Thessaloniki, Greece

11. University of Nigeria, Nigeria

12. The Chinese University of Hong Kong, China

13. Italian Kidney Foundation, Italy

Abstract

Abstract Historically, it takes an average of 17 years for new treatments to move from clinical evidence to daily practice. Given the highly effective treatments now available to prevent or delay kidney disease onset and progression, this is far too long. Now is the time to narrow the gap between what we know and what we do. Clear guidelines exist for the prevention and management of common risk factors for kidney disease, such as hypertension and diabetes, but only a fraction of people with these conditions are diagnosed worldwide, and even fewer are treated to target. Similarly, the vast majority of people living with kidney disease are unaware of their condition, because it is often silent in the early stages. Even among patients who have been diagnosed, many do not receive appropriate treatment for kidney disease. Considering the serious consequences of kidney disease progression, kidney failure, or death, it is imperative that treatments are initiated early and appropriately. Opportunities to diagnose and treat kidney disease early must be maximized beginning at the primary care level. Many systematic barriers exist, ranging from the patient to the clinician to the health systems to societal factors. To preserve and improve kidney health for everyone everywhere, each of these barriers must be acknowledged so that sustainable solutions are developed and implemented without further delay.

Publisher

FapUNIFESP (SciELO)

Reference67 articles.

1. A single number for advocacy and communication-worldwide more than 850 million individuals have kidney diseases;Jager KJ;Kidney Int,2019

2. GBD compare data visualization [Internet],2023

3. The global burden of kidney disease and the sustainable development goals;Luyckx VA;Bull World Health Organ,2018

4. ISN global kidney health atlas [Internet],2023

5. Lancet;Bikbov B,2020

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3